3 drug, the blood thinner Eliquis, reached $29 billion in sales, less than half the amount spent on each of the weight-loss drugs, ASHP's report said
Both the demand and supply of these drugs have exceeded all expectations and the momentum driving the market suggests they are highly likely to become a permanent feature of the food landscape. Manufacturers such as Nestle have responded, debuting its Vital Pursuit brand specifically designed to support GLP-1 consumer diets
Eli Lilly distributes tirzepatide under the Mounjaro brand name in Mexico, the same formulation used in the United States
Nat Protoc 5 , 5166 (2010)
Smooth and easy application is, of course, a necessary factor
After removing duplicates by title scanning, 69 articles were deemed suitable for analysis